Literature DB >> 21107897

Glutamine synthetase gene expression and glutamate transporters in C6-glioma cells.

Zafeer Baber1, Nasrin Haghighat.   

Abstract

Glutamine synthetase (GS) is the major glutamate-forming enzyme of vertebrae and is accepted to be a marker of astroglial cells. Maturation of astroglial cells is characterized by an increase in GS activity, and the regulation of this enzyme is the topic of many publications. The amino acid glutamate is the major excitatory neurotransmitter in the brain and mediates normal excitatory synaptic transmission by interaction with postsynaptic receptors. Glutamate also acts as a potent neurotoxin when present at high concentration. Glutamate neurotoxicity plays an important role in the pathophysiology of many neurological disorders, such as Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis. In the normal condition, L-glutamate is predominantly taken up, metabolized and recycled by astrocytes through the glutamate transporters (GLAST/GLT1) and glutamine synthetase (GS) catalytic activity. Because of the fundamental role of these glutamate transporters and the glutamine synthetase enzyme in controlling cerebral glutamate level, regulation of GS and studying of the glutamate transporters in glial cells is important. Astrocytes are supportive cells and act as the site of detoxification of glutamate in the brain. However, their isolation from the brain is a tedious, costly and time consuming procedure. On the other hand, the C6-glioma cells are readily available on the market. They are well characterized and have been a useful model for CNS glia in many laboratories. For this study, we used the C6-glioma cell line as a model system. We examined the presence or absence of glial specific glutamate transporters (GLTI and GLAST) in C6-glioma cells, which was done by immunocytochemistry. We also examined glutamine synthetase gene expression in these cells by treatment of the C6-glioma cells with estrogen (17ß estradiol). The findings from this study provide useful information about C6-glioma cells which makes the study of the CNS tremendously inexpensive.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107897     DOI: 10.1007/s11011-010-9223-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  34 in total

1.  Selective induction of glial glutamate transporter GLT-1 by hypertonic stress in C6 glioma cells.

Authors:  T Imura; S Shimohama; T Kageyama; J Kimura
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

Review 2.  Estradiol modulation of astrocytic form and function: implications for hormonal control of synaptic communication.

Authors:  J A Mong; T Blutstein
Journal:  Neuroscience       Date:  2005-12-02       Impact factor: 3.590

3.  Oestradiol up-regulates glutamine synthetase mRNA and protein expression in the hypothalamus and hippocampus: implications for a role of hormonally responsive glia in amino acid neurotransmission.

Authors:  T Blutstein; N Devidze; E Choleris; A M Jasnow; D W Pfaff; J A Mong
Journal:  J Neuroendocrinol       Date:  2006-09       Impact factor: 3.627

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Responses in primary astrocytes and C6-glioma cells to ammonium chloride and dibutyryl cyclic-AMP.

Authors:  N Haghighat; D W McCandless; P Geraminegad
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

6.  Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).

Authors:  L A Dowd; A J Coyle; J D Rothstein; D B Pritchett; M B Robinson
Journal:  Mol Pharmacol       Date:  1996-03       Impact factor: 4.436

7.  Cytoprotective effect of estrogen on ammonium chloride-treated C6-glioma cells.

Authors:  N Haghighat; M M Oblinger; D W McCandless
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

8.  Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina.

Authors:  Iftach Shaked; Iris Ben-Dror; Lily Vardimon
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

9.  Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter.

Authors:  T P Palos; B Ramachandran; R Boado; B D Howard
Journal:  Brain Res Mol Brain Res       Date:  1996-04

Review 10.  What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.

Authors:  T L Perry; S Hansen
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

View more
  5 in total

1.  Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells.

Authors:  Fernanda Hansen; Daniela Fraga de Souza; Simone da Luz Silveira; Ana Lúcia Hoefel; Júlia Bijoldo Fontoura; Ana Carolina Tramontina; Larissa Daniele Bobermin; Marina Concli Leite; Marcos Luiz Santos Perry; Carlos Alberto Gonçalves
Journal:  Metab Brain Dis       Date:  2012-07-18       Impact factor: 3.584

2.  Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism.

Authors:  Krista Minéia Wartchow; Ana Carolina Tramontina; Daniela F de Souza; Regina Biasibetti; Larissa D Bobermin; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2016-02-15       Impact factor: 3.996

3.  Glutamine synthetase functions as a negative growth regulator in glioma.

Authors:  Ying Yin; Weifeng Sun; Jie Xiang; Lingxiao Deng; Bin Zhang; Ping Xie; Weizhen Qiao; Jian Zou; Chunxing Liu
Journal:  J Neurooncol       Date:  2013-06-19       Impact factor: 4.130

4.  Methylglyoxal Induces Changes in the Glyoxalase System and Impairs Glutamate Uptake Activity in Primary Astrocytes.

Authors:  Fernanda Hansen; Fabiana Galland; Franciane Lirio; Daniela Fraga de Souza; Carollina Da Ré; Rafaela Ferreira Pacheco; Adriana Fernanda Vizuete; André Quincozes-Santos; Marina Concli Leite; Carlos-Alberto Gonçalves
Journal:  Oxid Med Cell Longev       Date:  2017-06-08       Impact factor: 6.543

5.  Involvement of the Notch pathway in terminal astrocytic differentiation: role of PKA.

Authors:  Carla Angulo-Rojo; Rebeca Manning-Cela; Adán Aguirre; Arturo Ortega; Esther López-Bayghen
Journal:  ASN Neuro       Date:  2013-12-23       Impact factor: 4.146

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.